The correction relates to around three million sensors used in Abbott’s FreeStyle Libre 3 and Libre 3 Plus CGMs in the US.

Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...

At least seven fires and one injury that were related to some FreeStyle Libre glucose monitor products have led the US Food and Drug Administration to issue a Class I recall, the agency's strongest, ...

The Abbott FreeStyle Libre has come as an entirely new concept in glucose monitoring by providing much greater data than blood glucose testing whilst being more affordable than continuous glucose ...

At least seven fires and one injury that were related to some FreeStyle Libre glucose monitor products have led the U.S. Food and Drug Administration to issue a Class I recall, the agency’s strongest, ...

The Food and Drug Administration (FDA) has cleared the FreeStyle ® Libre 2 iOS App for use with the FreeStyle Libre 2 14-day glucose sensors in individuals 4 years of age and older with diabetes. The ...

Daily glucose monitoring can often be a painful and tedious process that you are probably all too familiar with. Painful fingerpricks and having to carry the glucose monitoring device around and ...